Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
Date:3/6/2012

al approval of CTI's marketing authorization application (the "MAA") for Pixuvri to treat adult patients with multiple relapsed or refractory aggressive non-Hodgkin B-cell lymphomas ("NHL").

"We expect that in the next few months the European Commission should adopt the CHMP's opinion for this unmet medical need and for the first time patients with multiple relapsed or refractory aggressive NHL in the E.U. will have an approved therapy to treat their disease," stated James A. Bianco, M.D., CEO of Cell Therapeutics, Inc. "We are working with consultants on developing a staffing, resource and product launch plan for Europe so upon marketing authorization and national reimbursement approvals, we can be in a position to bring Pixuvri to these patients.  With approximately 12,000 potential patients each year in the EU(1) this represents an attractive initial commercial opportunity for CTI."

"At the same time, we are moving our other late stage product candidates forward including a March meeting with the U.S. Food and Drug Administration for the phase 3 tosedostat trial in myelodysplastic syndrome ("MDS"), a precursor of acute myeloid leukemia ("AML"). Additionally a multi-center, phase 2 study with OPAXIO treating malignant brain cancer is underway based on encouraging results from the previous study in this disease. With the potential commercial launch of Pixuvri, coupled with the successful in-licensing of tosedostat, we continue to explore additional novel clinical stage compounds to expand our hematologic cancer product pipeline," Bianco added.

  • EMA's CHMP granted a positive opinion for conditional approval of CTI's MAA for Pixuvri as monotherapy for the treatment of adult patients with multiple relapsed or refractory aggressive NHL.
  • The final OPAL phase 2 results of tosedostat, which demonstrated significant response rates in elderly patients with refractory or relapsed AML, were presented in an oral session at the American Soci
    '/>"/>

  • SOURCE Cell Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2011 Financial Results on March 7
    2. Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development
    3. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
    4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO Investor Forum
    5. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
    6. Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
    7. Intrinsic Therapeutics, Inc. Names Cary P. Hagan as President & CEO
    8. Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation
    9. Prefilled Syringes: Devices, Therapeutics, Players, Markets and Prospects
    10. Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
    11. Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
    (Date:8/29/2014)... WILSONVILLE, Ore. , Aug. 29, 2014 /PRNewswire-iReach/ ... its Accessory (Axilla) Strap for the SAM Junctional ... SAM Medical Products announced ... a voluntary recall to address a potential issue ... strap used for the Axilla application of the ...
    (Date:8/29/2014)...  A Boston Scientific Corporation (NYSE: ... and preliminary long term stricture resolution of benign ... issue of the peer-reviewed journal, Gastroenterology. ... conducted in 11 countries and five continents, and ... (FCSEMS) after extended indwell (i.e., up to 12 ...
    Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
    ... JERUSALEM , June 2, 2010 Oramed ... announced,today that its subsidiary Oramed Ltd. entered into a joint ... company listed on,the Tel Aviv Stock Exchange, for the establishment ... Under the terms of the agreement, Oramed,will out-license technology to ...
    ... June 1 The U.S. Food and Drug Administration today approved Prolia, ... for fractures. , , , ... ) , , , ... which the bones become weak and are more likely to break. According to ...
    Cached Medicine Technology:Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 2Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 3FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women 2FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women 3
    (Date:8/29/2014)... A recent article discusses the creation ... clothing store for men with gynecomastia, or male breasts, to ... their problem. Board-certified plastic surgeon Dr. Chasan is familiar with ... people only associate male breasts with men who are excessively ... of all ages, often starting in adolescence. Men with the ...
    (Date:8/29/2014)... Pursuing its deepest desires to help ... a stunning new design that promises to redefine the ... notable surrogacy platform has witnessed a 42 percent increase ... a month, the FindSurrogateMother.com community is formed by hopeful ... goal — the precious gift of life. , Whether ...
    (Date:8/29/2014)... report released yesterday by the Mental Health Commission ... health training and education that police personnel receive. ... issue for Canada,s police community, and today,s report ... enforcement and people with mental illnesses," says Queen,s ... an interest in the area of police psychology. ...
    (Date:8/29/2014)... D.C. (PRWEB) August 29, 2014 Today, ... Community Anti-Drug Coalitions of America (CADCA) , the nation’s ... in response to President Obama’s intent to nominate Michael ... , “CADCA strongly supports President Obama’s decision to nominate ... is the ideal person to hold this important position ...
    (Date:8/29/2014)... August 29, 2014 Thirteen Novant ... prestigious Great 100 Nurses in North Carolina ... nursing excellence and provides scholarships to nursing students at ... from Novant Health Presbyterian Medical Center are: ... Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen Smith, ...
    Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Great 100 Honors 13 Novant Health Nurses 2
    ... Prevention efforts ,have run out of steam, expert says, , , ... risk of dying prematurely? Don,t smoke and keep a healthy ... about one in five deaths among U.S. adults, according to ... to be linked with premature death, the magnitude of the ...
    ... East and the Asia-Pacific region , , TUESDAY, April 28 (HealthDay ... in the United States has doubled to 40, U.S. health ... a New York City high school that had previously reported ... Tuesday were listing the number of U.S. cases at 50, ...
    ... Trends Suggest These Agents Will Face Greater Use of ... on Commercial Health Plans, According to a New Report ... N.J., April 28 HealthLeaders-InterStudy and Fingertip ... antihypertensives are expected to face tougher formulary restrictions. According ...
    ... Doors with Offices in New York ... 28 Diversified Agency Services (DAS) today announced the launch ... New York and London. TogoRun specializes in healthcare, pharmaceutical ... roster includes many of the world,s leading healthcare brands.The new ...
    ... by Troops Coming Home from WarCAMBRIDGE, Mass., April 28 ... Veterans Affairs Appropriations Subcommittee on behalf of ALS patients, ... (ALS TDI), last Thursday. Dr. Appel urged congress ... such as the one at ALS TDI. Dr. ...
    ... 28 Verathon(R) is pleased to announce the new ... with Urologists in mind, the BVM 9500 measures both ... noninvasively to help diagnose bladder dysfunction, including BPH (benign ... new addition to the BladderScan(R) BVI 9000 series made ...
    Cached Medicine News:Health News:1 in 5 U.S. Deaths Attributed to Smoking, High BP 2Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 2Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 3Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 4Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 5Health News:Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions 2Health News:Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions 3Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 2Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 3Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 4Health News:ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs 2Health News:ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs 3Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 2Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: